GALECTIN-3 AS A MARKER FOR PROSTATE CANCER

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150377889A1
SERIAL NO

14768094

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided are methods and kits for the use of galectin-3, alone or in combination with prostate specific antigen (PSA), as a marker for the presence or absence of and/or activity of prostate cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
WAYNE STATE UNIVERSITY656 W KIRBY 4032 F/AB DETROIT MI 48202

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Balan, Vitaly Amherst, US 5 3
Heath, Elisabeth I Bloomfield Hills, US 3 0
Heilbrun, Lance K Beverly Hills, US 1 0
Raz, Avraham West Bloomfield, US 10 103

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation